Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-21 1:22 pm Purchase | 2023-01-12 | 13D | Emmaus Life Sciences, Inc. EMMA | Niihara Yutaka | 20,979,966 35.900% | 7,548,800 (+56.20%) | Filing History |
| 2022-11-09 1:33 pm Sale | 2022-05-18 | 13D | Emmaus Life Sciences, Inc. EMMA | Niihara Yutaka | 13,431,166 26.400% | -316,874 (-2.30%) | Filing History |
| 2022-02-16 7:21 pm Purchase | 2022-02-09 | 13D | Emmaus Life Sciences, Inc. EMMA | Niihara Yutaka | 13,748,040 26.600% | 142,950 (+1.05%) | Filing History |
| 2021-12-01 3:59 pm Purchase | 2021-11-19 | 13D | Emmaus Life Sciences, Inc. EMMA | Niihara Yutaka | 13,605,090 26.300% | 246,685 (+1.85%) | Filing History |
| 2021-07-22 11:13 am Purchase | 2021-05-13 | 13D | Emmaus Life Sciences, Inc. EMMA | Niihara Yutaka | 13,358,405 25.800% | 235,928 (+1.80%) | Filing History |
| 2020-04-02 4:29 pm Purchase | 2020-02-06 | 13D | Emmaus Life Sciences, Inc. EMMA | Niihara Yutaka | 13,122,477 25.700% | 342,770 (+2.68%) | Filing History |